A six-year clinical trial involving more than 6,800 older adults in Spain has produced one of the clearest signals yet that a Mediterranean diet, when combined with moderate calorie reduction and regular physical activity, can substantially lower the odds of developing type 2 diabetes. Published in May 2026 as a secondary analysis in the Annals of Internal Medicine, the findings from the PREDIMED-Plus trial show a 31 percent reduction in new diabetes cases among participants who followed the structured lifestyle program compared with those who ate a Mediterranean diet without calorie limits or exercise targets.
Perhaps more striking than the headline number: the protection held even among people who lost only a modest amount of weight. For the hundreds of millions of adults worldwide living with prediabetes or metabolic syndrome, that detail reframes the conversation. It suggests that sustainable changes in what you eat, how much you eat, and how often you move may matter more than chasing a number on the scale.
What the trial actually tested
PREDIMED-Plus enrolled adults aged 55 to 75 who had overweight or obesity and at least three features of metabolic syndrome, a cluster of conditions including high blood pressure, elevated blood sugar, and excess abdominal fat. The trial ran across 23 research centers in Spain and randomized participants into two groups.
The intervention arm followed an energy-reduced Mediterranean diet, aiming for roughly a 30 percent calorie deficit from estimated needs. Participants were also asked to walk briskly or perform equivalent moderate-intensity exercise for at least 150 minutes per week and attended regular one-on-one and group behavioral-coaching sessions. The control arm ate a traditional Mediterranean diet with no calorie cap and received only general dietary advice at annual check-ins.
Both groups consumed plenty of vegetables, legumes, whole grains, fish, nuts, and olive oil. The critical difference was energy balance and structured movement. That design lets researchers isolate the added value of calorie restraint and exercise on top of an already high-quality dietary pattern.
Over a median follow-up of approximately six years, the intervention group developed type 2 diabetes at a significantly lower rate. The 31 percent reduction is expressed as a hazard ratio, meaning the risk of being diagnosed with diabetes at any point during follow-up was roughly a third lower in the lifestyle-intervention arm after adjusting for baseline characteristics.
Why the weight-loss finding matters
Weight loss is often treated as the primary yardstick for diabetes-prevention programs. The landmark U.S. Diabetes Prevention Program, published in 2002, showed that a 7 percent loss of body weight combined with 150 minutes of weekly activity cut diabetes incidence by 58 percent over about three years. That result set the template for lifestyle interventions worldwide.
PREDIMED-Plus reported a smaller relative reduction, 31 percent, but over a longer follow-up period and in a population that was older and already carried multiple metabolic risk factors. Crucially, many participants in the intervention arm lost only a few kilograms. The investigators have emphasized that the diabetes benefit did not appear to hinge on large-scale weight loss, pointing instead to improvements in diet composition, insulin sensitivity, and chronic inflammation as likely drivers.
That distinction has real-world relevance. Most adults who attempt significant weight loss regain much of it within two to five years. A program that delivers meaningful metabolic protection without requiring dramatic or sustained weight reduction is, for many people, a more realistic path.
Building on PREDIMED’s legacy
The trial’s predecessor, the original PREDIMED study, demonstrated in 2014 that a Mediterranean diet supplemented with extra-virgin olive oil could reduce diabetes incidence even without a structured exercise or weight-loss component. PREDIMED-Plus was designed to push that finding further: would layering calorie restriction, physical activity, and behavioral support onto the same dietary framework yield additional protection?
The answer, based on this secondary analysis, appears to be yes. But the two trials differ in population, follow-up length, and intervention intensity, so a direct numerical comparison should be made cautiously. What the combined body of evidence does establish is a dose-response pattern: a Mediterranean diet alone helps, and a Mediterranean diet plus calorie moderation plus exercise helps more.
What the data do not yet show
Several important questions remain open. The published analysis reports the top-line hazard ratio and confidence intervals but does not break down how much of the benefit came from eating fewer calories versus moving more versus the behavioral coaching itself. Detailed accelerometry data and calorie-intake logs beyond the first year of the trial have not yet appeared in the peer-reviewed literature.
The claim that protection held independent of weight loss is consistent with the investigators’ framing, but individual-level biomarker trajectories, such as serial HbA1c or fasting insulin stratified by weight-change quartile, have been referenced only in summary form. Granular participant-level data linking specific lifestyle changes to specific physiologic shifts would strengthen the case considerably.
Long-term durability past the six-year mark is another gap. Lifestyle interventions frequently show diminishing returns as adherence fades. Whether the benefit persists at eight or ten years, and what it costs per case of diabetes prevented, are questions the current publication does not resolve. Cost-effectiveness analyses have appeared in institutional summaries from the European Research Council, which co-funded the trial, but have not yet been published in peer-reviewed form.
Finally, the trial population was composed of older Spanish adults with metabolic syndrome. How well the results translate to younger people, different ethnic groups, or individuals without metabolic syndrome is unknown. The Mediterranean diet has broad epidemiological support across many populations, but cultural factors, food access, and socioeconomic conditions all influence how feasible it is to adopt this pattern outside southern Europe.
How this compares to drug-based prevention
Metformin, the most studied pharmacological option for diabetes prevention, reduced incidence by about 31 percent in the U.S. Diabetes Prevention Program, a figure strikingly similar to the PREDIMED-Plus result. But metformin’s effect was smaller than the lifestyle arm in that same trial, and it came with medication costs and side effects. The PREDIMED-Plus data reinforce a consistent theme in diabetes-prevention research: well-designed lifestyle programs can match or exceed the protection offered by medication, particularly when they combine dietary improvement with physical activity and behavioral support.
That said, lifestyle programs require infrastructure, trained counselors, and sustained participant engagement, none of which are free. For health systems weighing where to invest, the outstanding cost-effectiveness data from PREDIMED-Plus will be an important piece of the puzzle.
What this means at the dinner table
For people trying to lower their own diabetes risk, the practical signal is straightforward even with the remaining uncertainties. A Mediterranean eating pattern built around vegetables, legumes, fish, whole grains, nuts, and olive oil, combined with moderate portion control and consistent physical activity most days of the week, produced a large and statistically significant reduction in new diabetes cases over six years. The benefit did not require extreme dieting or heavy exercise.
In concrete terms, the intervention group was counseled to fill half their plate with vegetables, use olive oil as the primary cooking fat, eat fish at least three times a week, limit red and processed meat, choose whole grains over refined ones, and snack on nuts rather than packaged foods. Calorie targets were individualized, but the general aim was a moderate deficit, not a crash diet. Physical activity centered on brisk walking, an exercise that requires no gym membership and no special equipment.
For clinicians, the findings support a recommendation that goes beyond “eat a Mediterranean diet.” The more precise message is: adopt a Mediterranean-style pattern with modest calorie restraint, aim for at least 150 minutes of moderate activity per week, and seek structured behavioral support when available. For policymakers, the trial underscores the potential return on investing in comprehensive lifestyle programs, while highlighting the need for replication in diverse populations and rigorous cost analyses before scaling globally.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
